Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

5
(from Reference Citation Analysis)

Article PDFs (3)

Cited by > 0 (4)

Searched Name

Galina Kirova-Nedyalkova

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Zlatanova T, Arabadjiev J, Kirova-Nedyalkova G, Nikova D. Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review. Front Oncol 2022;12:907321. [PMID: 36016602 PMCID: PMC9396293 DOI: 10.3389/fonc.2022.907321] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 07/14/2022] [Indexed: 11/30/2022] Open

Sun D, Hadjiiski L, Alva A, Zakharia Y, Joshi M, Chan HP, Garje R, Pomerantz L, Elhag D, Cohan RH, Caoili EM, Kerr WT, Cha KH, Kirova-Nedyalkova G, Davenport MS, Shankar PR, Francis IR, Shampain K, Meyer N, Barkmeier D, Woolen S, Palmbos PL, Weizer AZ, Samala RK, Zhou C, Matuszak M. Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study. Tomography 2022;8:644-656. [PMID: 35314631 PMCID: PMC8938803 DOI: 10.3390/tomography8020054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Revised: 02/17/2022] [Accepted: 02/28/2022] [Indexed: 11/22/2022] Open

Affiliation(s)

Di Sun Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.) Correspondence:
Lubomir Hadjiiski Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Ajjai Alva Department of Internal Medicine-Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109, USA; (A.A.); (P.L.P.)
Yousef Zakharia Department of Internal Medicine-Hematology/Oncology, University of Iowa, Iowa, IA 52242, USA; (Y.Z.); (R.G.); (D.E.)
Monika Joshi Department of Internal Medicine-Hematology/Oncology, Pennsylvania State University, Hershey, PA 16801, USA; (M.J.); (L.P.)
Heang-Ping Chan Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Rohan Garje Department of Internal Medicine-Hematology/Oncology, University of Iowa, Iowa, IA 52242, USA; (Y.Z.); (R.G.); (D.E.)
Lauren Pomerantz Department of Internal Medicine-Hematology/Oncology, Pennsylvania State University, Hershey, PA 16801, USA; (M.J.); (L.P.)
Dean Elhag Department of Internal Medicine-Hematology/Oncology, University of Iowa, Iowa, IA 52242, USA; (Y.Z.); (R.G.); (D.E.)
Richard H. Cohan Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Elaine M. Caoili Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Wesley T. Kerr Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA;
Kenny H. Cha U.S. Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, MD 20993, USA;
Galina Kirova-Nedyalkova Department of Radiology, Acibadem City Clinic, Tokuda Hospital, 1407 Sofia, Bulgaria;
Matthew S. Davenport Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.) Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA;
Prasad R. Shankar Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Isaac R. Francis Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Kimberly Shampain Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Nathaniel Meyer Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Daniel Barkmeier Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Sean Woolen Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Phillip L. Palmbos Department of Internal Medicine-Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109, USA; (A.A.); (P.L.P.)
Alon Z. Weizer Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA;
Ravi K. Samala Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Chuan Zhou Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA; (L.H.); (H.-P.C.); (R.H.C.); (E.M.C.); (M.S.D.); (P.R.S.); (I.R.F.); (K.S.); (N.M.); (D.B.); (S.W.); (R.K.S.); (C.Z.)
Martha Matuszak Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA;

Collapse

Hadjiiski LM, Cha KH, Cohan RH, Chan HP, Caoili EM, Davenport MS, Samala RK, Weizer AZ, Alva A, Kirova-Nedyalkova G, Shampain K, Meyer N, Barkmeier D, Woolen SA, Shankar PR, Francis IR, Palmbos PL. Intraobserver Variability in Bladder Cancer Treatment Response Assessment With and Without Computerized Decision Support. ACTA ACUST UNITED AC 2021;6:194-202. [PMID: 32548296 PMCID: PMC7289252 DOI: 10.18383/j.tom.2020.00013] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]

Georgiev E, Radeva R, Naseva E, Kirova-Nedyalkova G. COMPARISON OF RADIATION DOSE AND IMAGE QUALITY IN CTA OF THE PERIPHERAL ARTERIES. Radiat Prot Dosimetry 2019;186:437-442. [PMID: 31034552 DOI: 10.1093/rpd/ncz045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2018] [Revised: 02/25/2019] [Accepted: 03/12/2019] [Indexed: 06/09/2023]

Cha KH, Hadjiiski LM, Cohan RH, Chan HP, Caoili EM, Davenport MS, Samala RK, Weizer AZ, Alva A, Kirova-Nedyalkova G, Shampain K, Meyer N, Barkmeier D, Woolen S, Shankar PR, Francis IR, Palmbos P. Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support. Acad Radiol 2019;26:1137-1145. [PMID: 30424999 DOI: 10.1016/j.acra.2018.10.010] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 09/23/2018] [Accepted: 10/09/2018] [Indexed: 10/27/2022]

Abstract

RATIONALE AND OBJECTIVES

To evaluate whether a computed tomography (CT)-based computerized decision-support system for muscle-invasive bladder cancer treatment response assessment (CDSS-T) can improve identification of patients who have responded completely to neoadjuvant chemotherapy.

MATERIALS AND METHODS

Following Institutional Review Board approval, pre-chemotherapy and post-chemotherapy CT scans of 123 subjects with 157 muscle-invasive bladder cancer foci were collected retrospectively. CT data were analyzed with a CDSS-T that uses a combination of deep-learning convolutional neural network and radiomic features to distinguish muscle-invasive bladder cancers that have fully responded to neoadjuvant treatment from those that have not. Leave-one-case-out cross-validation was used to minimize overfitting. Five attending abdominal radiologists, four diagnostic radiology residents, two attending oncologists, and one attending urologist estimated the likelihood of pathologic T0 disease (complete response) by viewing paired pre/post-treatment CT scans placed side-by-side on an internally-developed graphical user interface. The observers provided an estimate without use of CDSS-T and then were permitted to revise their estimate after a CDSS-T-derived likelihood score was displayed. Observer estimates were analyzed with multi-reader, multi-case receiver operating characteristic methodology. The area under the curve (AUC) and the statistical significance of the difference were estimated.

RESULTS

The mean AUCs for assessment of pathologic T0 disease were 0.80 for CDSS-T alone, 0.74 for physicians not using CDSS-T, and 0.77 for physicians using CDSS-T. The increase in the physicians' performance was statistically significant (P < .05).

CONCLUSION

CDSS-T improves physician performance for identifying complete response of muscle-invasive bladder cancer to neoadjuvant chemotherapy.

Collapse